$IBIO Dr. Armstrong is a heavy hitter and an exceptional addition to the board. I have always been very excited about iBio 100. They started developing this drug well before COVID hit. It has orphan drug status. And it just so happens to treat COVID’s deadliest symptom. It is also in Dr. Armstrong’s wheelhouse. I think back to Tom discussing why vaccine development is so slow. You have to be extra careful since, from a medical ethics standpoint, you are putting a drug into healthy people to test. Therapeutics are a little different, as you are testing them on very ill people who may not have other options. I would not be surprised if 100 is the first to enter human trials.